Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Debopam Samanta

Concepts (323)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Epilepsy
27
2024
174
13.060
 Why?
Seizures
21
2024
196
4.940
 Why?
Spasms, Infantile
9
2024
27
4.080
 Why?
Anticonvulsants
12
2023
122
3.850
 Why?
Cannabidiol
5
2022
37
3.650
 Why?
Status Epilepticus
6
2021
39
3.540
 Why?
Tuberous Sclerosis
6
2022
37
3.490
 Why?
Mutation
16
2023
1293
3.260
 Why?
Electroencephalography
17
2022
306
2.480
 Why?
Humans
103
2024
49827
2.450
 Why?
Epilepsies, Myoclonic
4
2020
11
2.370
 Why?
Intellectual Disability
5
2023
124
2.330
 Why?
Hemiplegia
3
2021
11
2.160
 Why?
Brain
9
2019
1309
2.150
 Why?
Child
37
2024
6824
2.090
 Why?
Developmental Disabilities
5
2019
119
1.800
 Why?
Epilepsy, Absence
3
2019
11
1.760
 Why?
Magnetic Resonance Imaging
15
2019
1533
1.680
 Why?
Tumor Suppressor Proteins
3
2023
127
1.500
 Why?
Neuroaxonal Dystrophies
2
2022
8
1.500
 Why?
Nervous System Malformations
3
2020
17
1.480
 Why?
Folate Receptor 1
2
2022
24
1.460
 Why?
Epilepsies, Partial
2
2022
11
1.370
 Why?
Infant, Newborn, Diseases
2
2020
57
1.370
 Why?
Ketamine
2
2020
60
1.350
 Why?
Infant
18
2024
3551
1.280
 Why?
Neurocutaneous Syndromes
2
2019
6
1.230
 Why?
Child, Preschool
19
2024
3853
1.220
 Why?
Cadherins
2
2019
68
1.200
 Why?
Deep Brain Stimulation
2
2024
39
1.160
 Why?
Cerebral Arteries
2
2019
40
1.130
 Why?
Epilepsy, Generalized
2
2023
8
1.110
 Why?
Sirolimus
2
2017
62
1.090
 Why?
Angiofibroma
2
2015
5
1.060
 Why?
Facial Neoplasms
2
2015
21
1.040
 Why?
Nerve Tissue Proteins
2
2018
193
1.020
 Why?
Valproic Acid
2
2022
32
1.010
 Why?
Stroke
3
2019
492
0.960
 Why?
Thalamus
1
2024
36
0.950
 Why?
Male
33
2024
25093
0.940
 Why?
Pregnanolone
2
2023
6
0.930
 Why?
Female
29
2024
26329
0.910
 Why?
Landau-Kleffner Syndrome
1
2022
3
0.870
 Why?
Treatment Outcome
10
2024
5138
0.840
 Why?
Quality Improvement
2
2022
212
0.830
 Why?
Aphasia
1
2022
31
0.830
 Why?
Nervous System Diseases
2
2021
88
0.810
 Why?
Chromosome Deletion
3
2019
141
0.800
 Why?
Abnormalities, Multiple
3
2023
167
0.790
 Why?
Emergencies
1
2021
87
0.760
 Why?
Pharmaceutical Preparations
1
2021
76
0.760
 Why?
Angelman Syndrome
1
2020
1
0.750
 Why?
Transition to Adult Care
1
2020
17
0.740
 Why?
Immunoglobulins, Intravenous
1
2021
54
0.730
 Why?
Bone Diseases, Developmental
2
2023
14
0.730
 Why?
Tooth Abnormalities
2
2023
11
0.720
 Why?
Fenfluramine
1
2020
7
0.720
 Why?
Oligonucleotides, Antisense
1
2020
28
0.710
 Why?
Phenobarbital
1
2020
17
0.710
 Why?
Dioxolanes
1
2020
12
0.710
 Why?
Behavioral Symptoms
1
2019
2
0.710
 Why?
Flunarizine
1
2019
1
0.710
 Why?
Immunologic Factors
1
2021
114
0.700
 Why?
Excitatory Amino Acid Antagonists
1
2020
50
0.700
 Why?
Ocular Physiological Phenomena
1
2019
4
0.690
 Why?
Tetrasomy
1
2019
2
0.690
 Why?
Agenesis of Corpus Callosum
2
2018
10
0.690
 Why?
Chromosomes, Human, Pair 5
1
2019
17
0.680
 Why?
Sneddon Syndrome
1
2019
3
0.680
 Why?
Livedo Reticularis
1
2019
5
0.680
 Why?
Oral Ulcer
1
2019
3
0.680
 Why?
Behcet Syndrome
1
2019
7
0.670
 Why?
Calcium Channel Blockers
1
2019
62
0.670
 Why?
Transposases
1
2019
10
0.670
 Why?
Andersen Syndrome
1
2019
1
0.670
 Why?
Genetic Therapy
1
2020
114
0.660
 Why?
Hydrocephalus
1
2019
42
0.660
 Why?
Spinal Cord Diseases
1
2019
37
0.660
 Why?
Receptors, GABA-B
1
2019
11
0.660
 Why?
Vitiligo
1
2019
8
0.660
 Why?
Nephrotic Syndrome
2
2017
17
0.660
 Why?
Leukoencephalopathies
1
2019
14
0.660
 Why?
Autoimmune Diseases of the Nervous System
1
2019
9
0.660
 Why?
Cytochrome-c Oxidase Deficiency
1
2018
3
0.660
 Why?
Migraine Disorders
2
2020
47
0.650
 Why?
Edema
1
2019
67
0.650
 Why?
Electron Transport Complex IV
1
2018
25
0.650
 Why?
Cannabinoid Receptor Agonists
1
2019
49
0.650
 Why?
Cerebral Infarction
1
2018
39
0.650
 Why?
Muscle Weakness
1
2019
44
0.640
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2018
8
0.640
 Why?
Amino Acyl-tRNA Synthetases
1
2018
6
0.640
 Why?
Shab Potassium Channels
1
2018
2
0.640
 Why?
Optic Atrophy
1
2018
16
0.640
 Why?
Photic Stimulation
1
2018
60
0.640
 Why?
Physicians
1
2022
234
0.640
 Why?
Alopecia
1
2019
38
0.630
 Why?
Parents
1
2021
312
0.630
 Why?
Brain Edema
1
2018
41
0.630
 Why?
Lymphohistiocytosis, Hemophagocytic
1
2018
25
0.620
 Why?
Thrombocytopenia
1
2019
84
0.620
 Why?
Biomedical Research
1
2021
231
0.620
 Why?
Myoclonus
1
2018
9
0.620
 Why?
Artifacts
1
2018
53
0.620
 Why?
Mitochondrial Diseases
1
2018
42
0.610
 Why?
Autoimmune Diseases
1
2019
100
0.610
 Why?
Practice Guidelines as Topic
1
2020
448
0.600
 Why?
Neurodegenerative Diseases
1
2018
76
0.600
 Why?
Hearing Loss, Sensorineural
1
2018
75
0.580
 Why?
Osteochondrodysplasias
1
2017
13
0.580
 Why?
Adolescent
13
2024
6340
0.580
 Why?
Immunologic Deficiency Syndromes
1
2017
20
0.580
 Why?
Phenotype
2
2021
727
0.580
 Why?
Health Knowledge, Attitudes, Practice
1
2021
488
0.570
 Why?
Arteriosclerosis
1
2017
54
0.570
 Why?
Carotid Artery Diseases
1
2017
33
0.570
 Why?
Infant, Newborn
6
2024
2744
0.570
 Why?
Models, Biological
1
2020
728
0.570
 Why?
Drug Discovery
1
2017
85
0.570
 Why?
Child Development
1
2018
185
0.560
 Why?
Prenatal Exposure Delayed Effects
1
2018
181
0.560
 Why?
Cafe-au-Lait Spots
1
2016
2
0.550
 Why?
Skin
1
2019
407
0.540
 Why?
Erythema Infectiosum
1
2015
3
0.540
 Why?
Migraine with Aura
1
2015
4
0.540
 Why?
Leukoencephalitis, Acute Hemorrhagic
1
2015
3
0.540
 Why?
Williams Syndrome
1
2016
27
0.540
 Why?
Corpus Callosum
2
2023
28
0.540
 Why?
Sinus Pericranii
1
2015
1
0.530
 Why?
Syndrome
6
2024
234
0.530
 Why?
Parvovirus B19, Human
1
2015
17
0.530
 Why?
Pulmonary Embolism
1
2017
97
0.530
 Why?
Toes
1
2015
15
0.530
 Why?
SOS1 Protein
1
2015
2
0.530
 Why?
Electrodiagnosis
1
2015
12
0.530
 Why?
Crying
1
2015
4
0.530
 Why?
Moyamoya Disease
1
2015
7
0.530
 Why?
Iatrogenic Disease
1
2015
21
0.530
 Why?
Hyperventilation
1
2015
8
0.520
 Why?
Tuberculoma
1
2015
2
0.520
 Why?
Epilepsy, Benign Neonatal
1
2015
2
0.520
 Why?
Noonan Syndrome
1
2015
12
0.520
 Why?
Neurologic Examination
1
2015
77
0.520
 Why?
Encephalitis
1
2016
41
0.520
 Why?
Communication
3
2022
244
0.510
 Why?
Mutism
1
2015
3
0.510
 Why?
NAV1.2 Voltage-Gated Sodium Channel
1
2015
3
0.510
 Why?
Ocular Motility Disorders
1
2015
17
0.510
 Why?
TOR Serine-Threonine Kinases
1
2015
77
0.510
 Why?
Repressor Proteins
2
2023
151
0.500
 Why?
Diagnosis, Differential
7
2020
1036
0.500
 Why?
Trisomy
1
2014
31
0.500
 Why?
Influenza, Human
1
2015
85
0.490
 Why?
KCNQ2 Potassium Channel
1
2014
9
0.490
 Why?
Energy Drinks
1
2014
6
0.490
 Why?
Neurology
1
2015
41
0.480
 Why?
Vasoconstriction
1
2014
54
0.480
 Why?
Benzodiazepines
1
2014
70
0.470
 Why?
Osteomyelitis
1
2015
126
0.470
 Why?
Membrane Proteins
1
2016
342
0.460
 Why?
Sleep
1
2014
182
0.450
 Why?
Enzyme Inhibitors
1
2015
391
0.440
 Why?
Magnetic Resonance Angiography
3
2019
77
0.420
 Why?
Immunosuppressive Agents
3
2019
220
0.420
 Why?
Pediatrics
1
2015
277
0.400
 Why?
Quality of Life
3
2022
833
0.380
 Why?
Receptors, N-Methyl-D-Aspartate
2
2022
126
0.360
 Why?
Diffusion Magnetic Resonance Imaging
3
2017
123
0.360
 Why?
Caregivers
2
2021
206
0.340
 Why?
Recurrence
3
2019
651
0.330
 Why?
Echinocandins
1
2008
64
0.320
 Why?
Mycoses
1
2008
158
0.300
 Why?
Gastroesophageal Reflux
2
2019
49
0.290
 Why?
Antifungal Agents
1
2008
339
0.270
 Why?
Administration, Topical
2
2015
54
0.260
 Why?
Retrospective Studies
6
2023
6117
0.260
 Why?
Adult
5
2024
13160
0.240
 Why?
Intralaminar Thalamic Nuclei
1
2024
6
0.240
 Why?
Psychosurgery
1
2023
5
0.230
 Why?
Databases, Factual
2
2024
664
0.230
 Why?
Laser Therapy
1
2023
83
0.220
 Why?
Speech Disorders
1
2022
16
0.220
 Why?
Ethosuximide
1
2022
5
0.210
 Why?
Clonazepam
1
2022
5
0.210
 Why?
Electrodes, Implanted
1
2022
30
0.210
 Why?
Stereotaxic Techniques
1
2022
37
0.210
 Why?
Cluster Analysis
1
2023
235
0.210
 Why?
Death, Sudden
1
2022
10
0.210
 Why?
GTPase-Activating Proteins
1
2022
23
0.210
 Why?
Palliative Care
1
2024
187
0.200
 Why?
Concept Formation
1
2021
12
0.200
 Why?
Perivascular Epithelioid Cell Neoplasms
1
2021
4
0.200
 Why?
Freedom
1
2021
3
0.200
 Why?
Folic Acid
1
2022
135
0.200
 Why?
Diazepam
1
2021
17
0.200
 Why?
Drug Interactions
1
2022
206
0.190
 Why?
Fibroma
1
2021
39
0.190
 Why?
Risk Factors
2
2020
3619
0.190
 Why?
Adrenocorticotropic Hormone
2
2022
31
0.190
 Why?
Personal Satisfaction
1
2021
75
0.190
 Why?
Soft Tissue Neoplasms
1
2021
57
0.190
 Why?
Brain Diseases
1
2021
82
0.190
 Why?
Dihydroergotamine
1
2020
4
0.190
 Why?
Perception
1
2021
116
0.180
 Why?
Facies
2
2023
35
0.180
 Why?
Transcription Factors
2
2023
563
0.180
 Why?
Diet Therapy
1
2020
8
0.180
 Why?
Consensus
1
2021
143
0.180
 Why?
Genetic Diseases, Inborn
1
2020
24
0.180
 Why?
Ubiquitin-Protein Ligases
1
2020
88
0.180
 Why?
Clinical Protocols
1
2020
108
0.180
 Why?
Treatment Failure
1
2020
113
0.180
 Why?
Anesthetics
1
2020
37
0.170
 Why?
Leukomalacia, Periventricular
1
2019
12
0.170
 Why?
Qualitative Research
1
2021
325
0.170
 Why?
Muscle Hypotonia
1
2019
21
0.170
 Why?
Matrix Attachment Region Binding Proteins
1
2020
33
0.170
 Why?
Chromosomes, Human, Pair 7
1
2019
29
0.170
 Why?
HLA-B51 Antigen
1
2019
2
0.170
 Why?
Learning
1
2021
158
0.170
 Why?
Patient-Centered Care
1
2021
128
0.170
 Why?
Craniofacial Abnormalities
1
2019
26
0.170
 Why?
Ventriculoperitoneal Shunt
1
2019
26
0.170
 Why?
Analgesics, Non-Narcotic
1
2020
116
0.170
 Why?
Heart Septal Defects, Atrial
1
2019
44
0.170
 Why?
Potassium Channels, Inwardly Rectifying
1
2019
7
0.170
 Why?
Ventricular Premature Complexes
1
2019
7
0.170
 Why?
Disease Management
1
2020
174
0.170
 Why?
Randomized Controlled Trials as Topic
1
2022
553
0.170
 Why?
Microcephaly
1
2019
41
0.160
 Why?
Melkersson-Rosenthal Syndrome
1
2018
4
0.160
 Why?
Facial Nerve Diseases
1
2018
6
0.160
 Why?
Referral and Consultation
1
2021
287
0.160
 Why?
Syncope
1
2019
28
0.160
 Why?
Nocturnal Myoclonus Syndrome
1
2018
13
0.160
 Why?
Cerebral Veins
1
2018
15
0.160
 Why?
Facial Paralysis
1
2018
24
0.160
 Why?
Health Personnel
1
2021
241
0.160
 Why?
Anti-Arrhythmia Agents
1
2019
79
0.160
 Why?
Deglutition Disorders
1
2019
77
0.160
 Why?
Acute Disease
1
2019
369
0.160
 Why?
Fatal Outcome
1
2019
195
0.160
 Why?
Video Recording
1
2018
80
0.160
 Why?
Frameshift Mutation
1
2018
17
0.160
 Why?
Fibrinolytic Agents
1
2019
125
0.160
 Why?
Clinical Trials as Topic
1
2020
460
0.150
 Why?
Combined Modality Therapy
1
2020
636
0.150
 Why?
Anti-Inflammatory Agents
1
2019
162
0.150
 Why?
Fear
1
2018
81
0.150
 Why?
India
1
2017
51
0.150
 Why?
Platelet Aggregation Inhibitors
1
2019
174
0.150
 Why?
History, 21st Century
1
2017
57
0.150
 Why?
Cerebellum
1
2018
133
0.150
 Why?
History, 20th Century
1
2017
100
0.150
 Why?
Methotrexate
1
2017
67
0.150
 Why?
Neurotoxicity Syndromes
1
2017
46
0.150
 Why?
Pandemics
1
2021
554
0.140
 Why?
Anti-Infective Agents
1
2017
97
0.140
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
91
0.140
 Why?
Animals
3
2022
13150
0.140
 Why?
Aldehyde Dehydrogenase
1
2016
26
0.140
 Why?
Hormones
1
2016
55
0.130
 Why?
Influenza B virus
1
2015
6
0.130
 Why?
Delayed Diagnosis
1
2016
23
0.130
 Why?
Chromosomes, Human, Pair 3
1
2015
19
0.130
 Why?
Arkansas
1
2021
1967
0.130
 Why?
North America
1
2015
66
0.130
 Why?
Cerebral Angiography
1
2015
96
0.130
 Why?
Antibiotics, Antineoplastic
1
2015
78
0.120
 Why?
Chromosomes, Human, Pair 9
1
2014
19
0.120
 Why?
Complementary Therapies
1
2015
25
0.120
 Why?
Brain Waves
1
2014
18
0.120
 Why?
Drug Resistance
1
2015
63
0.120
 Why?
Antiemetics
1
2014
32
0.120
 Why?
Polymerase Chain Reaction
1
2015
455
0.120
 Why?
Headache
1
2014
76
0.120
 Why?
Mutation, Missense
1
2014
103
0.120
 Why?
Vomiting
1
2014
74
0.120
 Why?
Glutamine
1
2015
171
0.120
 Why?
Arginine
1
2015
179
0.110
 Why?
Analgesics
1
2014
101
0.110
 Why?
Decision Making, Computer-Assisted
1
2013
4
0.110
 Why?
Diagnostic Errors
1
2013
63
0.110
 Why?
Vigabatrin
2
2022
2
0.110
 Why?
Evidence-Based Medicine
1
2013
248
0.100
 Why?
Inflammation
1
2016
604
0.100
 Why?
Pregnancy
1
2018
2584
0.100
 Why?
Signal Transduction
1
2017
1617
0.090
 Why?
Dysentery
1
2009
1
0.080
 Why?
Trichuriasis
1
2009
1
0.080
 Why?
Trichuris
1
2009
1
0.080
 Why?
Antineoplastic Agents
1
2017
1172
0.080
 Why?
Anesthesia, Intravenous
1
2008
13
0.080
 Why?
Eosinophils
1
2009
38
0.080
 Why?
Lipopeptides
1
2008
63
0.080
 Why?
Amyloidosis
1
2009
78
0.080
 Why?
Inflammatory Bowel Diseases
1
2009
53
0.080
 Why?
Tuberculosis
1
2009
141
0.080
 Why?
Candidiasis
1
2008
114
0.080
 Why?
Aspergillosis
1
2008
125
0.070
 Why?
Kidney Diseases
1
2009
214
0.070
 Why?
Prospective Studies
2
2023
2344
0.070
 Why?
Spasm
1
2024
9
0.060
 Why?
Feedback
1
2024
53
0.060
 Why?
Probability
1
2023
164
0.060
 Why?
Neuroimaging
1
2023
82
0.050
 Why?
Neurosurgical Procedures
1
2024
121
0.050
 Why?
Potassium Channels
1
2021
31
0.050
 Why?
Registries
1
2024
518
0.050
 Why?
Administration, Intravenous
1
2020
68
0.050
 Why?
Sleep Stages
1
2020
45
0.040
 Why?
Age of Onset
1
2020
106
0.040
 Why?
Cognition
1
2022
336
0.040
 Why?
Immunohistochemistry
1
2021
971
0.040
 Why?
Software
1
2013
273
0.020
 Why?
Internet
1
2013
261
0.020
 Why?
Young Adult
1
2020
3936
0.020
 Why?
Mebendazole
1
2009
2
0.020
 Why?
Antinematodal Agents
1
2009
3
0.020
 Why?
Leukemoid Reaction
1
2009
6
0.020
 Why?
Antitubercular Agents
1
2009
106
0.020
 Why?
Colonoscopy
1
2009
93
0.020
 Why?
Prognosis
1
2009
1952
0.010
 Why?
Samanta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (323) concept(s)
_
Co-Authors Expand Description
See all (13) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department